Therapy of Autochthonous Skin Cancers in Mice with Intravenously Injected Liposomes Containing Muramyltripeptide1

J. E. Talmadge, B. F. Lenz, R. Klabansky, C. Riggs, S. Guo, R. Simon, R. K. Oldham, I. J. Fidler

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Liposomes containing the immunomodulator muramyltripep-tide phosphatidylethanolamine (MTP-PE) or free saline were injected i.v. into BALB/c mice with autochthonous skin cancers induced by chronic exposure to ultraviolet irradiation. Treatment with liposomes containing MTP-PE produced significant retardation in the growth of the primary autochthonous skin cancers and significantly prolonged survival of the treated mice as compared with the saline-treated controls. Since ultraviolet-irradiated mice have a defect in immunological recognition of their autochthonous tumors, the therapeutic effects of liposomes containing MTP-PE are very encouraging. These results suggest that liposomes containing MTP-PE could be used for the treatment of patients with skin cancer or other malignant diseases.

Original languageEnglish (US)
Pages (from-to)1160-1163
Number of pages4
JournalCancer Research
Volume46
Issue number3
StatePublished - Mar 1 1986

Fingerprint

Skin Neoplasms
Liposomes
Immunologic Factors
Therapeutic Uses
Therapeutics
Survival
phosphatidylethanolamine
Growth
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Talmadge, J. E., Lenz, B. F., Klabansky, R., Riggs, C., Guo, S., Simon, R., ... Fidler, I. J. (1986). Therapy of Autochthonous Skin Cancers in Mice with Intravenously Injected Liposomes Containing Muramyltripeptide1. Cancer Research, 46(3), 1160-1163.

Therapy of Autochthonous Skin Cancers in Mice with Intravenously Injected Liposomes Containing Muramyltripeptide1. / Talmadge, J. E.; Lenz, B. F.; Klabansky, R.; Riggs, C.; Guo, S.; Simon, R.; Oldham, R. K.; Fidler, I. J.

In: Cancer Research, Vol. 46, No. 3, 01.03.1986, p. 1160-1163.

Research output: Contribution to journalArticle

Talmadge, JE, Lenz, BF, Klabansky, R, Riggs, C, Guo, S, Simon, R, Oldham, RK & Fidler, IJ 1986, 'Therapy of Autochthonous Skin Cancers in Mice with Intravenously Injected Liposomes Containing Muramyltripeptide1', Cancer Research, vol. 46, no. 3, pp. 1160-1163.
Talmadge, J. E. ; Lenz, B. F. ; Klabansky, R. ; Riggs, C. ; Guo, S. ; Simon, R. ; Oldham, R. K. ; Fidler, I. J. / Therapy of Autochthonous Skin Cancers in Mice with Intravenously Injected Liposomes Containing Muramyltripeptide1. In: Cancer Research. 1986 ; Vol. 46, No. 3. pp. 1160-1163.
@article{a8465151d599471e96831cecb3d53c59,
title = "Therapy of Autochthonous Skin Cancers in Mice with Intravenously Injected Liposomes Containing Muramyltripeptide1",
abstract = "Liposomes containing the immunomodulator muramyltripep-tide phosphatidylethanolamine (MTP-PE) or free saline were injected i.v. into BALB/c mice with autochthonous skin cancers induced by chronic exposure to ultraviolet irradiation. Treatment with liposomes containing MTP-PE produced significant retardation in the growth of the primary autochthonous skin cancers and significantly prolonged survival of the treated mice as compared with the saline-treated controls. Since ultraviolet-irradiated mice have a defect in immunological recognition of their autochthonous tumors, the therapeutic effects of liposomes containing MTP-PE are very encouraging. These results suggest that liposomes containing MTP-PE could be used for the treatment of patients with skin cancer or other malignant diseases.",
author = "Talmadge, {J. E.} and Lenz, {B. F.} and R. Klabansky and C. Riggs and S. Guo and R. Simon and Oldham, {R. K.} and Fidler, {I. J.}",
year = "1986",
month = "3",
day = "1",
language = "English (US)",
volume = "46",
pages = "1160--1163",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Therapy of Autochthonous Skin Cancers in Mice with Intravenously Injected Liposomes Containing Muramyltripeptide1

AU - Talmadge, J. E.

AU - Lenz, B. F.

AU - Klabansky, R.

AU - Riggs, C.

AU - Guo, S.

AU - Simon, R.

AU - Oldham, R. K.

AU - Fidler, I. J.

PY - 1986/3/1

Y1 - 1986/3/1

N2 - Liposomes containing the immunomodulator muramyltripep-tide phosphatidylethanolamine (MTP-PE) or free saline were injected i.v. into BALB/c mice with autochthonous skin cancers induced by chronic exposure to ultraviolet irradiation. Treatment with liposomes containing MTP-PE produced significant retardation in the growth of the primary autochthonous skin cancers and significantly prolonged survival of the treated mice as compared with the saline-treated controls. Since ultraviolet-irradiated mice have a defect in immunological recognition of their autochthonous tumors, the therapeutic effects of liposomes containing MTP-PE are very encouraging. These results suggest that liposomes containing MTP-PE could be used for the treatment of patients with skin cancer or other malignant diseases.

AB - Liposomes containing the immunomodulator muramyltripep-tide phosphatidylethanolamine (MTP-PE) or free saline were injected i.v. into BALB/c mice with autochthonous skin cancers induced by chronic exposure to ultraviolet irradiation. Treatment with liposomes containing MTP-PE produced significant retardation in the growth of the primary autochthonous skin cancers and significantly prolonged survival of the treated mice as compared with the saline-treated controls. Since ultraviolet-irradiated mice have a defect in immunological recognition of their autochthonous tumors, the therapeutic effects of liposomes containing MTP-PE are very encouraging. These results suggest that liposomes containing MTP-PE could be used for the treatment of patients with skin cancer or other malignant diseases.

UR - http://www.scopus.com/inward/record.url?scp=0022549481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022549481&partnerID=8YFLogxK

M3 - Article

C2 - 3943092

AN - SCOPUS:0022549481

VL - 46

SP - 1160

EP - 1163

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 3

ER -